Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

Also called NCT01069302

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01069302
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01069302. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2011-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan
Acronym
CHOICE
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Clopidogrel
Lead sponsor
Takeshi Morimoto (class: other)

Record details

Record id
cardio:ct-nct01069302
Content hash
b80d2d9f6009bffbfcb57bd50f4c88108e88e2f063a4f655c93cd2fe7dc7a82f